United States · FDA National Drug Code directory

Nucynta ER

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
24510-174_2d370c0d-8d66-446f-be46-ed92e0f1cf6b
Product NDC
24510-174
Form
TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term
tapentadol hydrochloride
Labeler
Collegium Pharmaceutical, Inc.
Marketing category
NDA
Marketing start / end (source format)
20190419
Source listing expiry
20271231

Source-listed ingredients

  • TAPENTADOL HYDROCHLORIDE — 150 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 BLISTER PACK in 1 CARTON (24510-174-01) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 24510-174-01
  • 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-174-60) · 24510-174-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →